AR111910A2 - IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS - Google Patents
IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODSInfo
- Publication number
- AR111910A2 AR111910A2 ARP180101457A ARP180101457A AR111910A2 AR 111910 A2 AR111910 A2 AR 111910A2 AR P180101457 A ARP180101457 A AR P180101457A AR P180101457 A ARP180101457 A AR P180101457A AR 111910 A2 AR111910 A2 AR 111910A2
- Authority
- AR
- Argentina
- Prior art keywords
- adjuvant
- formulation
- formulations
- adjuster
- procedure
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 11
- 238000009472 formulation Methods 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 230000002163 immunogen Effects 0.000 title abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 7
- 108091034117 Oligonucleotide Proteins 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 230000003308 immunostimulating effect Effects 0.000 abstract 3
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 abstract 2
- 229920002307 Dextran Polymers 0.000 abstract 2
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 229930182558 Sterol Natural products 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 208000004396 mastitis Diseases 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 150000003432 sterols Chemical class 0.000 abstract 1
- 235000003702 sterols Nutrition 0.000 abstract 1
- 150000003648 triterpenes Chemical class 0.000 abstract 1
- 239000007762 w/o emulsion Substances 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Formulaciones de adyuvante que comprenden diversas combinaciones de triterpenoides, esteroles, inmunomoduladores, polímeros y estimuladores de Th2; procedimientos para preparar las composiciones de adyuvante; y el uso de las formulaciones de adyuvante en composiciones inmunogénicas y de vacunas con diferentes antígenos. Uso de las formulaciones en el tratamiento de animales (mastitis). Reivindicación 1: Una composición de vacuna que comprende un componente de antígeno y un componente adyuvante, en donde el componente de antígeno comprende bacterina de E. coli J-5, y el componente adyuvante comprende: DEAE dextrano, un oligonucleótido inmunoestimulador que contiene CpG y un aceite. Reivindicación 4: Una formulación de adyuvante que comprende DEAE dextrano, un oligonucleótido inmunoestimulador y aceite, en donde el oligonucleótido inmunoestimulador es un ODN que contiene CpG, y en el que la formulación de adyuvante es la emulsión de agua en aceite (W / O).Adjuvant formulations comprising various combinations of triterpenoids, sterols, immunomodulators, polymers and Th2 stimulators; procedures for preparing adjuvant compositions; and the use of adjuvant formulations in immunogenic compositions and of vaccines with different antigens. Use of formulations in the treatment of animals (mastitis). Claim 1: A vaccine composition comprising an antigen component and an adjuvant component, wherein the antigen component comprises E. coli J-5 bacterin, and the adjuvant component comprises: DEAE dextran, an immunostimulatory oligonucleotide containing CpG and an oil. Claim 4: An adjuvant formulation comprising DEAE dextran, an immunostimulatory oligonucleotide and oil, wherein the immunostimulatory oligonucleotide is an ODN containing CpG, and wherein the adjuvant formulation is the water-in-oil emulsion (W / O) .
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7623208P | 2008-06-27 | 2008-06-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR111910A2 true AR111910A2 (en) | 2019-08-28 |
Family
ID=52297695
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180101457A AR111910A2 (en) | 2008-06-27 | 2018-05-31 | IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS |
| ARP180101458A AR111911A2 (en) | 2008-06-27 | 2018-05-31 | IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180101458A AR111911A2 (en) | 2008-06-27 | 2018-05-31 | IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS |
Country Status (2)
| Country | Link |
|---|---|
| AR (2) | AR111910A2 (en) |
| UA (1) | UA104138C2 (en) |
-
2009
- 2009-06-24 UA UAA201013068A patent/UA104138C2/en unknown
-
2018
- 2018-05-31 AR ARP180101457A patent/AR111910A2/en unknown
- 2018-05-31 AR ARP180101458A patent/AR111911A2/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AR111911A2 (en) | 2019-08-28 |
| UA104138C2 (en) | 2014-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6331297A2 (en) | NEW ADVANCING COMPOSITIONS | |
| CR10559A (en) | INFLUENZA VACCINE | |
| AR053833A1 (en) | IMMUNOGENETIC COMPOSITION | |
| CR11122A (en) | WATER OIL EMULSION INFLUENZA VACCINE | |
| BRPI1013780B8 (en) | IMMUNOGENIC COMPOSITION USEFUL FOR IMMUNIZATION AGAINST STAPHYLOCOCCUS AUREUS, ITS PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION | |
| MX2010007815A (en) | Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions. | |
| NO20091022L (en) | Vaccine comprising an oil in water emulsion adjuvant | |
| UY28398A1 (en) | IMMUNIZATION METHOD AND PATCH BY MICROPROJECTION PROVISION | |
| NZ733383A (en) | Oil-based adjuvants | |
| BR0007936A (en) | Compound, immunological adjuvant formulation, vaccine formulation, and process to stimulate an immune response to an antigen | |
| PE20151588A1 (en) | VACCINE AGAINST DENGUE VIRUS | |
| CY1116904T1 (en) | VACCINE | |
| EP2377551A3 (en) | Adjuvanted influenza vaccines including cytokine-inducing agents | |
| AR103427A1 (en) | VACCINE AGAINST AFTOSE FEVER | |
| BR112023021812A2 (en) | ADJUVANT VACCINE COMPOSITION AND METHODS | |
| EA201001478A1 (en) | VACCINE | |
| AU2001284354A1 (en) | Immunological adjuvant compounds, compositions, and methods of use thereof | |
| AR111910A2 (en) | IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS | |
| CY1113746T1 (en) | VACCINE INCLUDING IMMUNE OIL OIL EMULSION MILK | |
| CU23244A1 (en) | VACCINATION FORMULATION POTENTIATED BY THE COMBINATION OF A DNA WITH AN ANTIGEN | |
| Bertrand et al. | Adjuvant formulations designed to improve swine vaccine stability: application to PCV2 vaccines. | |
| UY29429A1 (en) | IMMUNOGENIC COMPOSITION CONTAINING VIRUSES OF THE FLU OR ANCIENT PREPARATION OF THE SAME, ITS USES AND PREPARATION PROCEDURES. | |
| AR042035A1 (en) | USE OF RMLT AS AN OLD MARKER FOR VACCINES AND AS A SYNERGIC ADDITIVE WITH AMPHIGEN | |
| TH2001003528A (en) | Vaccines against Hendra and Nipah virus infections | |
| SG160386A1 (en) | Novel composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |